Skip to main content
logo
Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
133.78
+3.13 (2.40%)
At close: Mar 10, 2026

Revenue

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Process Solutions Revenue
3.79B3.52B
Process Solutions Revenue Growth
7.46%-6.87%
Life Science Services Revenue
658.90M721.80M
Life Science Services Revenue Growth
-8.71%-8.89%
Science & Lab Solutions Revenue
4.54B4.67B
Science & Lab Solutions Revenue Growth
-2.91%-0.73%
Life Science Revenue
8.98B8.92B
Life Science Revenue Growth
0.71%-3.93%
Oncology Revenue
1.93B2.01B
Oncology Revenue Growth
-4.17%10.47%
Neurology & Immunology Revenue
1.66B1.69B
Neurology & Immunology Revenue Growth
-1.75%1.39%
Fertility Revenue
1.46B1.53B
Fertility Revenue Growth
-4.64%-1.27%
Cardiovascular, Metabolism and Endocrinology Revenue
3.05B2.95B
Cardiovascular, Metabolism and Endocrinology Revenue Growth
3.44%5.83%
Other Healthcare Revenue
328.00M280.50M
Other Healthcare Revenue Growth
16.93%19.16%
Healthcare Revenue
8.61B8.45B
Healthcare Revenue Growth
1.81%4.98%
Display Solutions Revenue
772.50M748.30M
Display Solutions Revenue Growth
3.23%-2.77%
Surface Solutions Revenue
248.60M406.50M
Surface Solutions Revenue Growth
-38.84%-1.07%
Semiconductor Solutions Revenue
2.49B2.63B
Semiconductor Solutions Revenue Growth
-5.20%6.13%
Electronics Revenue
3.51B3.79B
Electronics Revenue Growth
-7.15%3.45%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Europe Revenue
6.42B6.17B
Europe Revenue Growth
3.99%2.21%
North America Revenue
5.52B5.71B
North America Revenue Growth
-3.37%-4.06%
Asia Pacific Revenue
6.94B7.02B
Asia Pacific Revenue Growth
-1.16%1.18%
Latin America Revenue
1.45B1.48B
Latin America Revenue Growth
-2.02%10.91%
Middle East & Africa Revenue
784.60M781.20M
Middle East & Africa Revenue Growth
0.43%5.98%

EBITDA

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Life Science EBITDA
2.59B2.59B
Life Science EBITDA Growth
-0.16%-8.17%
Healthcare EBITDA
3.08B2.99B
Healthcare EBITDA Growth
2.83%17.75%
Electronics EBITDA
832.60M969.60M
Electronics EBITDA Growth
-14.13%6.20%
Corporate/Others EBITDA
-388.30M-481.80M
Updated Dec 31, 2025. Data Source: Fiscal.ai.